Short Interest in NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Decreases By 95.0%

NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) was the target of a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 900 shares, a decline of 95.0% from the November 30th total of 18,100 shares. Based on an average daily volume of 23,300 shares, the days-to-cover ratio is currently 0.0 days.

NLS Pharmaceutics Stock Up 75.0 %

Shares of NLS Pharmaceutics stock traded up $0.01 during trading on Thursday, reaching $0.02. The company’s stock had a trading volume of 50,518 shares, compared to its average volume of 21,383. The company has a 50-day simple moving average of $0.01 and a two-hundred day simple moving average of $0.02. NLS Pharmaceutics has a 1-year low of $0.01 and a 1-year high of $0.10.

About NLS Pharmaceutics

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).